16-1494312-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_016111.4(TELO2):c.31G>A(p.Ala11Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00112 in 1,613,332 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_016111.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TELO2 | NM_016111.4 | c.31G>A | p.Ala11Thr | missense_variant | 2/21 | ENST00000262319.11 | NP_057195.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TELO2 | ENST00000262319.11 | c.31G>A | p.Ala11Thr | missense_variant | 2/21 | 1 | NM_016111.4 | ENSP00000262319 | P1 | |
TELO2 | ENST00000497339.6 | c.31G>A | p.Ala11Thr | missense_variant, NMD_transcript_variant | 2/12 | 5 | ENSP00000456383 |
Frequencies
GnomAD3 genomes AF: 0.000940 AC: 143AN: 152122Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00136 AC: 342AN: 250950Hom.: 1 AF XY: 0.00144 AC XY: 195AN XY: 135746
GnomAD4 exome AF: 0.00114 AC: 1671AN: 1461092Hom.: 12 Cov.: 33 AF XY: 0.00117 AC XY: 853AN XY: 726844
GnomAD4 genome AF: 0.000939 AC: 143AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.000846 AC XY: 63AN XY: 74438
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at